Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMPIS- Congenital Myopathy Intervention Study. An Open-label, Cross Over, Randomised, Controlled Study Using Oral Salbutamol

NCT05099107 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT05099107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05099107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMPIS- Congenital Myopathy Intervention Study. An Open-label, Cross Over, Randomised, Controlled Study Using Oral Salbutamol
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Completed
Start date
October 25, 2021
Completion date
March 17, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

centronuclear myopathy, congenital myopathy, musculoskeletal diseases, myosin storage myopathy, nemaline myopathy, neuromuscular diseases